Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Epizyme Inc patents

Recent patent applications related to Epizyme Inc. Epizyme Inc is listed as an Agent/Assignee. Note: Epizyme Inc may have other listings under different names/spellings. We're not affiliated with Epizyme Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "E" | Epizyme Inc-related inventors




Date Epizyme Inc patents (updated weekly) - BOOKMARK this page
08/17/17 new patent  Combination therapy for treating cancer
08/17/17 new patent  Prmt1 inhibitors and uses thereof
08/10/17Prmt5 inhibitors and uses thereof
08/03/17Ezh2 inhibitors for treating lymphoma
08/03/17Substituted benzene and 6,5-fused bicyclic heteroaryl compounds
07/27/17Prmt5 inhibitors and uses thereof
07/13/17Prmt5 inhibitors and uses thereof
07/06/17Isoxazole carboxamide compounds
06/29/17Prmt1 inhibitors and uses thereof
06/15/17Method of treating leukemia
05/25/17Salt form of a human histone methyltransferase ezh2 inhibitor
05/18/17Inhibitors of protein methyltransferase dot1l and methods of use thereof
05/04/17Arginine methyltransferase inhibitors and uses thereof
05/04/17Aryl- or heteroaryl-substituted benzene compounds
04/27/17Prmt5 inhibitors and uses thereof
03/30/17Arginine methyltransferase inhibitors and uses thereof
03/30/17Prmt5 inhibitors and uses thereof
03/23/17Combination therapy for treating cancer
03/09/17Inhibitors of human ezh2, and methods of use thereof
03/09/17Inhibitors of human ezh2, and methods of use thereof
03/02/17Carm1 inhibitors and uses thereof
03/02/17Arginine methyltransferase inhibitors and uses thereof
02/02/17Prmt5 inhibitors and uses thereof
12/22/16Prmt5 inhibitors and uses thereof
12/22/16Substituted purine compounds
12/01/16Method for treating cancer
11/17/16Substituted benzene compounds
11/10/16Substituted 6,5-fused bicyclic heteroaryl compounds
10/20/16Combination therapy for treating cancer
10/13/16Methods for treating cancer
10/06/16Methods of synthesizing substituted purine compounds
09/01/167-deazapurine modulators of histone methyltransferase, and methods of use thereof
08/25/16Substituted benzene compounds
08/18/16Hydrochloride salt form for ezh2 inhibition
08/11/16Method of treating cancer
07/28/16Prmt5 inhibitors and uses thereof
07/07/16Substituted benzene compounds
06/30/16Arginine methyltransferase inhibitors and uses thereof
06/30/16Arginine methyltransferase inhibitors and uses thereof
06/02/16Substituted 6,5-fused bicyclic heteroaryl compounds
05/19/16Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof
05/19/16Prmt5 inhibitors and uses thereof
04/21/16Arginine methyltransferase inhibitors and uses thereof
03/10/16Modulators of histone methyltransferase, and methods of use thereof
02/25/161-phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
02/25/161-phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
02/18/16Combination therapy for treating cancer
02/11/16Pyrazole derivatives as prmt1 inhibitors and uses thereof
02/11/16Carm1 inhibitors and uses thereof
02/04/16Arginine methyltransferase inhibitors and uses thereof
02/04/16Substituted benzene compounds
01/28/16Aryl- or heteroaryl-substituted benzene compounds
01/28/16Injectable formulations for treating cancer
01/28/16Arginine methyltransferase inhibitors and uses thereof
01/28/16Arginine methyltransferase inhibitors and uses thereof
01/28/16Substituted 6,5-fused bicyclic heteroaryl compounds
01/28/16Methods of synthesizing substituted purine compounds
12/24/15Substituted purine and 7-deazapurine compounds
12/17/15Prmt5 inhibitors and uses thereof
12/10/15Substituted benzene compounds
12/10/15Aryl- or heteroaryl-substituted benzene compounds
12/03/15Dot1l inhibitors for use in the treatment of leukemia
12/03/151,4-pyridone compounds
12/03/15Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
12/03/15Tetrahydro- and dihydro-isoquinoline prmt5 inhibitors and uses thereof
Patent Packs
12/03/15Methods of inhibiting prmt5
12/03/151,4-pyridone bicyclic heteroaryl compounds
12/03/15Prmt5 inhibitors and uses thereof
10/08/15Prmt1 inhibitors and uses thereof
10/08/15Substituted benzene compounds
10/08/15Inhibitors of protein methyltransferase dot1l and methods of use thereof
09/24/15Substituted 6,5-fused bicyclic heteroaryl compounds
09/10/15Prmt5 inhibitors and uses thereof
09/03/15Substituted 6, 5-fused bicyclic heteroaryl compounds
08/06/15Method of treating leukemia
07/09/15Prmt5 inhibitors and uses thereof
06/25/15Substituted benzene compounds
05/21/15Inhibitors of human ezh2, and methods of use thereof
05/14/15Prmt5 inhibitors and uses thereof
03/05/15Substituted 6,5-fused bicyclic heteroaryl compounds
Patent Packs
03/05/15Salt form of a human histone methyltransferase ezh2 inhibitor
02/19/15Combination therapy for treating cancer
01/08/15Methods of synthesizing substituted purine compounds
11/06/14Prmt5 inhibitors and uses thereof
10/30/14Combination therapy for treating cancer
10/30/14Arginine methyltransferase inhibitors and uses thereof
10/23/14Arginine methyltransferase inhibitors and uses thereof
10/23/14Substituted benzene compounds
10/23/14Arginine methyltransferase inhibitors and uses thereof
10/02/14Substituted 6,5-fused bicyclic heteroaryl compounds
09/25/14Aryl- or heteroaryl-substituted benzene compounds
09/25/14Carm1 inhibitors and uses thereof
09/25/14Arginine methyltransferase inhibitors and uses thereof
09/25/14Arginine methyltransferase inhibitors and uses thereof
09/25/14Arginine methyltransferase inhibitors and uses thereof
09/25/14Prmt1 inhibitors and uses thereof
09/25/14Prmt1 inhibitors and uses thereof
09/25/14Prmt1 inhibitors and uses thereof
09/18/14Inhibitors of human ezh2, and methods of use thereof
08/14/14Prmt5 inhibitors and uses thereof
08/14/14Prmt5 inhibitors and uses thereof
08/07/14Prmt5 inhibitors and uses thereof
07/31/14Prmt5 inhibitors and uses thereof
05/22/14Substituted benzene compounds
05/08/14Methods of treating cancer
03/13/147-deazapurine modulators of histone methyltransferase, and methods of use thereof
02/27/14Substituted 6,5-fused bicyclic heteroaryl compounds
02/20/14Substituted purine and 7-deazapurine compounds
12/19/13Carbocycle-substituted purine and 7-deazapurine compounds
11/28/13Substituted 6,5-fused bicyclic heteroaryl compounds
Social Network Patent Pack
11/21/13Modulators of histone methyltransferase, and methods of use thereof
11/21/137-deazapurine modulators of histone methyltransferase, and methods of use thereof
05/16/13Aryl- or heteroaryl-substituted benzene compounds
06/07/12Substituted purine and 7-deazapurine compounds
03/22/12Inhibitors of human ezh2 and methods of use thereof







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Epizyme Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Epizyme Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';